Search Results For:
- Search results for:
- Gates Foundation - CureVac, Global Access Commitments Agreement
(Click + to show provisions)
Agreement title
Effective date
Partner type
Technology
Development stage
Gates Foundation - CureVac, Global Access Commitments Agreement
2015
Funder
Industry
Industry
Drug
Vaccine
Vaccine
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
Field Testing
Late clinical (Phase 3)
Commercialization
Field Testing
- Equitable Access | Ensuring continuity
- Equitable Access | Access plans & principles
- Equitable Access | Affordable pricing
- Equitable Access | Territory access commitments
- Business model | Governance
- Business model | Payment Structures
- Protecting & sharing information | Confidentiality
- Protecting & sharing information | Information sharing
- Protecting & sharing information | Publication of Results
- Intellectual Property | Ownership of IP
- Intellectual Property | Protection of IP
- Liability | Indemnification & liability
- Liability | Insurance
- Liability | Representations & Warranties
- Term & termination | Term of agreement
- Term & termination | Termination & withdrawal
Gates Foundation - CureVac - GSK, Letter Agreement for Alignment on Global Access Commitments
2020
Funder
Industry
Industry
Drug
Vaccine
Vaccine
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
- Equitable Access | Ensuring continuity
- Equitable Access | Access plans & principles
- Protecting & sharing information | Confidentiality
- Protecting & sharing information | Information sharing
- Protecting & sharing information | Publication of Results
- Intellectual Property | License Grants
- Intellectual Property | Ownership of IP
- Liability | Representations & Warranties
- Term & termination | Term of agreement
GHIAA2019\MapguideSearch Object
(
[search_parameters] => Array
(
[qs] => Gates Foundation - CureVac, Global Access Commitments Agreement
)
[filters] => Array
(
[text_search] => Gates Foundation - CureVac, Global Access Commitments Agreement
)
[child_filters] => Array
(
)
[agreement_args] =>
[provision_args] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[post__in] => Array
(
[0] => 4857
[1] => 3369
[2] => 3367
[3] => 3365
[4] => 3362
[5] => 3359
[6] => 3358
[7] => 3357
[8] => 3355
[9] => 3353
[10] => 3350
[11] => 3347
[12] => 3346
[13] => 3345
[14] => 3335
[15] => 4855
[16] => 4853
[17] => 3379
[18] => 3378
[19] => 3377
[20] => 3376
[21] => 3375
)
)
[text_agreement_args] => Array
(
[post_type] => agreement
[posts_per_page] => -1
[s] => Gates Foundation - CureVac, Global Access Commitments Agreement
)
[text_provision_args] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[s] => Gates Foundation - CureVac, Global Access Commitments Agreement
)
[agreement_ids] => Array
(
)
[agreement_q_rslts] =>
[provision_q_rslts] =>
[text_agreement_q_rslts] => WP_Query Object
(
[query] => Array
(
[post_type] => agreement
[posts_per_page] => -1
[s] => Gates Foundation - CureVac, Global Access Commitments Agreement
)
[query_vars] => Array
(
[post_type] => agreement
[posts_per_page] => -1
[s] => Gates Foundation - CureVac, Global Access Commitments Agreement
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[search_columns] => Array
(
)
[orderby] => title
[order] => ASC
[suppress_filters] =>
[ignore_sticky_posts] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] => 1
[comments_per_page] => 50
[no_found_rows] =>
[search_terms_count] => 8
[search_terms] => Array
(
[0] => Gates
[1] => Foundation
[2] => CureVac
[3] => Global
[4] => Access
[5] => Commitments
[6] => Agreement
)
[search_orderby_title] => Array
(
[0] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Gates{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[1] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Foundation{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[2] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}CureVac{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[3] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Global{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[4] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Access{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[5] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Commitments{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[6] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Agreement{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
)
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wpry_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] =>
SELECT DISTINCT wpry_posts.*
FROM wpry_posts INNER JOIN wpry_postmeta AS a ON ( a.post_id = wpry_posts.ID ) LEFT JOIN wpry_postmeta AS b ON ( (( b.post_id = a.post_id )) AND (( b.meta_key LIKE CONCAT( '\_', a.meta_key ) )) ) LEFT JOIN wpry_posts AS c ON ( ( c.post_name = b.meta_value ) AND ( c.post_type = 'acf-field' ) AND (( c.post_content LIKE '%:"text"%' ) OR ( c.post_content LIKE '%:"textarea"%' ) OR ( c.post_content LIKE '%:"wysiwyg"%' ) OR ( c.post_content LIKE '%:"checkbox"%' )) )
WHERE 1=1 AND ( ( ( b.meta_id IS NOT NULL ) AND ( c.ID IS NOT NULL ) AND ( a.meta_value LIKE '%Gates%' ) AND ( a.meta_value LIKE '%Foundation%' ) AND ( a.meta_value LIKE '%-%' ) AND ( a.meta_value LIKE '%CureVac,%' ) AND ( a.meta_value LIKE '%Global%' ) AND ( a.meta_value LIKE '%Access%' ) AND ( a.meta_value LIKE '%Commitments%' ) AND ( a.meta_value LIKE '%Agreement%' ) ) OR ( ( ( wpry_posts.post_title LIKE '%Gates%' ) OR ( wpry_posts.post_content LIKE '%Gates%' ) OR ( wpry_posts.post_excerpt LIKE '%Gates%' ) ) AND ( ( wpry_posts.post_title LIKE '%Foundation%' ) OR ( wpry_posts.post_content LIKE '%Foundation%' ) OR ( wpry_posts.post_excerpt LIKE '%Foundation%' ) ) AND ( ( wpry_posts.post_title LIKE '%-%' ) OR ( wpry_posts.post_content LIKE '%-%' ) OR ( wpry_posts.post_excerpt LIKE '%-%' ) ) AND ( ( wpry_posts.post_title LIKE '%CureVac,%' ) OR ( wpry_posts.post_content LIKE '%CureVac,%' ) OR ( wpry_posts.post_excerpt LIKE '%CureVac,%' ) ) AND ( ( wpry_posts.post_title LIKE '%Global%' ) OR ( wpry_posts.post_content LIKE '%Global%' ) OR ( wpry_posts.post_excerpt LIKE '%Global%' ) ) AND ( ( wpry_posts.post_title LIKE '%Access%' ) OR ( wpry_posts.post_content LIKE '%Access%' ) OR ( wpry_posts.post_excerpt LIKE '%Access%' ) ) AND ( ( wpry_posts.post_title LIKE '%Commitments%' ) OR ( wpry_posts.post_content LIKE '%Commitments%' ) OR ( wpry_posts.post_excerpt LIKE '%Commitments%' ) ) AND ( ( wpry_posts.post_title LIKE '%Agreement%' ) OR ( wpry_posts.post_content LIKE '%Agreement%' ) OR ( wpry_posts.post_excerpt LIKE '%Agreement%' ) ) ) ) AND ((wpry_posts.post_type = 'agreement' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
ORDER BY wpry_posts.post_title ASC
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 3333
[post_author] => 6
[post_date] => 2021-06-30 12:11:59
[post_date_gmt] => 2021-06-30 12:11:59
[post_content] =>
[post_title] => Gates Foundation - CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2022-10-11 12:17:55
[post_modified_gmt] => 2022-10-11 12:17:55
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=agreement&p=3333
[menu_order] => 0
[post_type] => agreement
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 1
[current_post] => -1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 3333
[post_author] => 6
[post_date] => 2021-06-30 12:11:59
[post_date_gmt] => 2021-06-30 12:11:59
[post_content] =>
[post_title] => Gates Foundation - CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2022-10-11 12:17:55
[post_modified_gmt] => 2022-10-11 12:17:55
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=agreement&p=3333
[menu_order] => 0
[post_type] => agreement
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 1
[max_num_pages] => 0
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] => 1
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] => 1
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] =>
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] => 1
[query_vars_hash:WP_Query:private] => 9a2dc0965d86506013b59c1448227169
[query_vars_changed:WP_Query:private] => 1
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] => Array
(
[0] => about
[1] => an
[2] => are
[3] => as
[4] => at
[5] => be
[6] => by
[7] => com
[8] => for
[9] => from
[10] => how
[11] => in
[12] => is
[13] => it
[14] => of
[15] => on
[16] => or
[17] => that
[18] => the
[19] => this
[20] => to
[21] => was
[22] => what
[23] => when
[24] => where
[25] => who
[26] => will
[27] => with
[28] => www
)
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
[text_provision_q_rslts] => WP_Query Object
(
[query] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[s] => Gates Foundation - CureVac, Global Access Commitments Agreement
)
[query_vars] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[s] => Gates Foundation - CureVac, Global Access Commitments Agreement
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[search_columns] => Array
(
)
[suppress_filters] =>
[ignore_sticky_posts] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] => 1
[comments_per_page] => 50
[no_found_rows] =>
[search_terms_count] => 8
[search_terms] => Array
(
[0] => Gates
[1] => Foundation
[2] => CureVac
[3] => Global
[4] => Access
[5] => Commitments
[6] => Agreement
)
[search_orderby_title] => Array
(
[0] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Gates{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[1] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Foundation{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[2] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}CureVac{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[3] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Global{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[4] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Access{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[5] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Commitments{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
[6] => wpry_posts.post_title LIKE '{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}Agreement{5789b4f4f43ae5dc58a852bb21d010346ee81cb57c4a210b7d878453007ad049}'
)
[order] => DESC
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wpry_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] =>
SELECT DISTINCT wpry_posts.*
FROM wpry_posts INNER JOIN wpry_postmeta AS a ON ( a.post_id = wpry_posts.ID ) LEFT JOIN wpry_postmeta AS b ON ( (( b.post_id = a.post_id )) AND (( b.meta_key LIKE CONCAT( '\_', a.meta_key ) )) ) LEFT JOIN wpry_posts AS c ON ( ( c.post_name = b.meta_value ) AND ( c.post_type = 'acf-field' ) AND (( c.post_content LIKE '%:"text"%' ) OR ( c.post_content LIKE '%:"textarea"%' ) OR ( c.post_content LIKE '%:"wysiwyg"%' ) OR ( c.post_content LIKE '%:"checkbox"%' )) )
WHERE 1=1 AND ( ( ( b.meta_id IS NOT NULL ) AND ( c.ID IS NOT NULL ) AND ( a.meta_value LIKE '%Gates%' ) AND ( a.meta_value LIKE '%Foundation%' ) AND ( a.meta_value LIKE '%-%' ) AND ( a.meta_value LIKE '%CureVac,%' ) AND ( a.meta_value LIKE '%Global%' ) AND ( a.meta_value LIKE '%Access%' ) AND ( a.meta_value LIKE '%Commitments%' ) AND ( a.meta_value LIKE '%Agreement%' ) ) OR ( ( ( wpry_posts.post_title LIKE '%Gates%' ) OR ( wpry_posts.post_content LIKE '%Gates%' ) OR ( wpry_posts.post_excerpt LIKE '%Gates%' ) ) AND ( ( wpry_posts.post_title LIKE '%Foundation%' ) OR ( wpry_posts.post_content LIKE '%Foundation%' ) OR ( wpry_posts.post_excerpt LIKE '%Foundation%' ) ) AND ( ( wpry_posts.post_title LIKE '%-%' ) OR ( wpry_posts.post_content LIKE '%-%' ) OR ( wpry_posts.post_excerpt LIKE '%-%' ) ) AND ( ( wpry_posts.post_title LIKE '%CureVac,%' ) OR ( wpry_posts.post_content LIKE '%CureVac,%' ) OR ( wpry_posts.post_excerpt LIKE '%CureVac,%' ) ) AND ( ( wpry_posts.post_title LIKE '%Global%' ) OR ( wpry_posts.post_content LIKE '%Global%' ) OR ( wpry_posts.post_excerpt LIKE '%Global%' ) ) AND ( ( wpry_posts.post_title LIKE '%Access%' ) OR ( wpry_posts.post_content LIKE '%Access%' ) OR ( wpry_posts.post_excerpt LIKE '%Access%' ) ) AND ( ( wpry_posts.post_title LIKE '%Commitments%' ) OR ( wpry_posts.post_content LIKE '%Commitments%' ) OR ( wpry_posts.post_excerpt LIKE '%Commitments%' ) ) AND ( ( wpry_posts.post_title LIKE '%Agreement%' ) OR ( wpry_posts.post_content LIKE '%Agreement%' ) OR ( wpry_posts.post_excerpt LIKE '%Agreement%' ) ) ) ) AND ((wpry_posts.post_type = 'provision_document' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
ORDER BY wpry_posts.post_date DESC
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 4855
[post_author] => 5
[post_date] => 2022-06-01 11:59:15
[post_date_gmt] => 2022-06-01 11:59:15
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-7
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:39:39
[post_modified_gmt] => 2022-08-11 09:39:39
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=4855
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 4853
[post_author] => 5
[post_date] => 2022-06-01 11:47:22
[post_date_gmt] => 2022-06-01 11:47:22
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-6
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:40:07
[post_modified_gmt] => 2022-08-11 09:40:07
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=4853
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 3379
[post_author] => 5
[post_date] => 2021-06-30 17:56:54
[post_date_gmt] => 2021-06-30 17:56:54
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-5
[to_ping] =>
[pinged] =>
[post_modified] => 2022-10-12 13:39:06
[post_modified_gmt] => 2022-10-12 13:39:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3379
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 3378
[post_author] => 5
[post_date] => 2021-06-30 17:55:17
[post_date_gmt] => 2021-06-30 17:55:17
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-4
[to_ping] =>
[pinged] =>
[post_modified] => 2023-04-12 09:46:22
[post_modified_gmt] => 2023-04-12 09:46:22
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3378
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[4] => WP_Post Object
(
[ID] => 3377
[post_author] => 5
[post_date] => 2021-06-30 17:20:14
[post_date_gmt] => 2021-06-30 17:20:14
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-3
[to_ping] =>
[pinged] =>
[post_modified] => 2022-09-26 14:42:01
[post_modified_gmt] => 2022-09-26 14:42:01
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3377
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[5] => WP_Post Object
(
[ID] => 3376
[post_author] => 5
[post_date] => 2021-06-30 16:38:25
[post_date_gmt] => 2021-06-30 16:38:25
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-2
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:54:45
[post_modified_gmt] => 2022-08-11 09:54:45
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3376
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[6] => WP_Post Object
(
[ID] => 3375
[post_author] => 5
[post_date] => 2021-06-30 16:36:27
[post_date_gmt] => 2021-06-30 16:36:27
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:55:12
[post_modified_gmt] => 2022-08-11 09:55:12
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3375
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 7
[current_post] => -1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 4855
[post_author] => 5
[post_date] => 2022-06-01 11:59:15
[post_date_gmt] => 2022-06-01 11:59:15
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-7
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:39:39
[post_modified_gmt] => 2022-08-11 09:39:39
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=4855
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 7
[max_num_pages] => 0
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] => 1
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] => 1
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] =>
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] => 1
[query_vars_hash:WP_Query:private] => 47b006335a32aa24624d53c308cdceed
[query_vars_changed:WP_Query:private] => 1
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] => Array
(
[0] => about
[1] => an
[2] => are
[3] => as
[4] => at
[5] => be
[6] => by
[7] => com
[8] => for
[9] => from
[10] => how
[11] => in
[12] => is
[13] => it
[14] => of
[15] => on
[16] => or
[17] => that
[18] => the
[19] => this
[20] => to
[21] => was
[22] => what
[23] => when
[24] => where
[25] => who
[26] => will
[27] => with
[28] => www
)
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
[provisions] => Array
(
[0] => WP_Post Object
(
[ID] => 4857
[post_author] => 5
[post_date] => 2022-06-02 10:16:52
[post_date_gmt] => 2022-06-02 10:16:52
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-15
[to_ping] =>
[pinged] =>
[post_modified] => 2022-10-12 11:06:21
[post_modified_gmt] => 2022-10-12 11:06:21
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=4857
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 4855
[post_author] => 5
[post_date] => 2022-06-01 11:59:15
[post_date_gmt] => 2022-06-01 11:59:15
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-7
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:39:39
[post_modified_gmt] => 2022-08-11 09:39:39
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=4855
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 4853
[post_author] => 5
[post_date] => 2022-06-01 11:47:22
[post_date_gmt] => 2022-06-01 11:47:22
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-6
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:40:07
[post_modified_gmt] => 2022-08-11 09:40:07
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=4853
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 3379
[post_author] => 5
[post_date] => 2021-06-30 17:56:54
[post_date_gmt] => 2021-06-30 17:56:54
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-5
[to_ping] =>
[pinged] =>
[post_modified] => 2022-10-12 13:39:06
[post_modified_gmt] => 2022-10-12 13:39:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3379
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[4] => WP_Post Object
(
[ID] => 3378
[post_author] => 5
[post_date] => 2021-06-30 17:55:17
[post_date_gmt] => 2021-06-30 17:55:17
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-4
[to_ping] =>
[pinged] =>
[post_modified] => 2023-04-12 09:46:22
[post_modified_gmt] => 2023-04-12 09:46:22
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3378
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[5] => WP_Post Object
(
[ID] => 3377
[post_author] => 5
[post_date] => 2021-06-30 17:20:14
[post_date_gmt] => 2021-06-30 17:20:14
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-3
[to_ping] =>
[pinged] =>
[post_modified] => 2022-09-26 14:42:01
[post_modified_gmt] => 2022-09-26 14:42:01
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3377
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[6] => WP_Post Object
(
[ID] => 3376
[post_author] => 5
[post_date] => 2021-06-30 16:38:25
[post_date_gmt] => 2021-06-30 16:38:25
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments-2
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:54:45
[post_modified_gmt] => 2022-08-11 09:54:45
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3376
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[7] => WP_Post Object
(
[ID] => 3375
[post_author] => 5
[post_date] => 2021-06-30 16:36:27
[post_date_gmt] => 2021-06-30 16:36:27
[post_content] =>
[post_title] => Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:55:12
[post_modified_gmt] => 2022-08-11 09:55:12
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3375
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[8] => WP_Post Object
(
[ID] => 3369
[post_author] => 6
[post_date] => 2021-06-30 15:09:50
[post_date_gmt] => 2021-06-30 15:09:50
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-14
[to_ping] =>
[pinged] =>
[post_modified] => 2023-04-27 13:19:12
[post_modified_gmt] => 2023-04-27 13:19:12
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3369
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[9] => WP_Post Object
(
[ID] => 3367
[post_author] => 6
[post_date] => 2021-06-30 14:55:06
[post_date_gmt] => 2021-06-30 14:55:06
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-13
[to_ping] =>
[pinged] =>
[post_modified] => 2022-09-29 11:26:57
[post_modified_gmt] => 2022-09-29 11:26:57
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3367
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[10] => WP_Post Object
(
[ID] => 3365
[post_author] => 6
[post_date] => 2021-06-30 14:51:27
[post_date_gmt] => 2021-06-30 14:51:27
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-12
[to_ping] =>
[pinged] =>
[post_modified] => 2022-10-12 13:39:38
[post_modified_gmt] => 2022-10-12 13:39:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3365
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[11] => WP_Post Object
(
[ID] => 3362
[post_author] => 6
[post_date] => 2021-06-30 14:47:24
[post_date_gmt] => 2021-06-30 14:47:24
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-11
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:57:29
[post_modified_gmt] => 2022-08-11 09:57:29
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3362
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[12] => WP_Post Object
(
[ID] => 3359
[post_author] => 6
[post_date] => 2021-06-30 14:38:46
[post_date_gmt] => 2021-06-30 14:38:46
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-10
[to_ping] =>
[pinged] =>
[post_modified] => 2023-05-05 08:01:22
[post_modified_gmt] => 2023-05-05 08:01:22
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3359
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[13] => WP_Post Object
(
[ID] => 3358
[post_author] => 6
[post_date] => 2021-06-30 13:47:23
[post_date_gmt] => 2021-06-30 13:47:23
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-9
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:58:14
[post_modified_gmt] => 2022-08-11 09:58:14
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3358
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[14] => WP_Post Object
(
[ID] => 3357
[post_author] => 6
[post_date] => 2021-06-30 13:41:11
[post_date_gmt] => 2021-06-30 13:41:11
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-8
[to_ping] =>
[pinged] =>
[post_modified] => 2023-05-17 10:25:31
[post_modified_gmt] => 2023-05-17 10:25:31
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3357
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[15] => WP_Post Object
(
[ID] => 3355
[post_author] => 6
[post_date] => 2021-06-30 13:30:36
[post_date_gmt] => 2021-06-30 13:30:36
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-7
[to_ping] =>
[pinged] =>
[post_modified] => 2023-04-27 13:18:24
[post_modified_gmt] => 2023-04-27 13:18:24
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3355
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[16] => WP_Post Object
(
[ID] => 3353
[post_author] => 6
[post_date] => 2021-06-30 13:25:17
[post_date_gmt] => 2021-06-30 13:25:17
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-6
[to_ping] =>
[pinged] =>
[post_modified] => 2022-09-26 14:40:35
[post_modified_gmt] => 2022-09-26 14:40:35
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3353
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[17] => WP_Post Object
(
[ID] => 3350
[post_author] => 6
[post_date] => 2021-06-30 13:18:18
[post_date_gmt] => 2021-06-30 13:18:18
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-5
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-11 09:48:11
[post_modified_gmt] => 2022-08-11 09:48:11
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3350
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[18] => WP_Post Object
(
[ID] => 3347
[post_author] => 6
[post_date] => 2021-06-30 13:12:31
[post_date_gmt] => 2021-06-30 13:12:31
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-4
[to_ping] =>
[pinged] =>
[post_modified] => 2023-05-05 08:01:59
[post_modified_gmt] => 2023-05-05 08:01:59
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3347
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[19] => WP_Post Object
(
[ID] => 3346
[post_author] => 6
[post_date] => 2021-06-30 13:07:59
[post_date_gmt] => 2021-06-30 13:07:59
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-3
[to_ping] =>
[pinged] =>
[post_modified] => 2022-12-14 15:50:41
[post_modified_gmt] => 2022-12-14 15:50:41
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3346
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[20] => WP_Post Object
(
[ID] => 3345
[post_author] => 6
[post_date] => 2021-06-30 13:04:52
[post_date_gmt] => 2021-06-30 13:04:52
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement-2
[to_ping] =>
[pinged] =>
[post_modified] => 2023-03-29 07:58:21
[post_modified_gmt] => 2023-03-29 07:58:21
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3345
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[21] => WP_Post Object
(
[ID] => 3335
[post_author] => 6
[post_date] => 2021-06-30 12:20:18
[post_date_gmt] => 2021-06-30 12:20:18
[post_content] =>
[post_title] => Gates Foundation – CureVac, Global Access Commitments Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => bmgf-curevac-global-access-commitments-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2023-05-01 14:20:42
[post_modified_gmt] => 2023-05-01 14:20:42
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=3335
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[invalid_get] =>
[is_text_search] => 1
[has_agreement_filters] =>
[has_any_agreement_filter] => Array
(
)
[found_agreements] =>
[has_provision_filters] =>
[found_provisions] => 1
[lbl_quick_search:GHIAA2019\MapguideSearch:private] => Search results for:
[lbl_issue:GHIAA2019\MapguideSearch:private] => Issue:
[lbl_key_term:GHIAA2019\MapguideSearch:private] => Key Term:
[lbl_agreement_type:GHIAA2019\MapguideSearch:private] => Agreement Type:
[lbl_partner_type:GHIAA2019\MapguideSearch:private] => Partner Type:
[lbl_technology:GHIAA2019\MapguideSearch:private] => Technology:
[lbl_development_stage:GHIAA2019\MapguideSearch:private] => Development Stage:
[issues_by_id:GHIAA2019\MapguideSearch:private] => Array
(
[101] => WP_Term Object
(
[term_id] => 101
[name] => Access plans & principles
[slug] => equitable-access
[term_group] => 0
[term_taxonomy_id] => 101
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 31
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[100] => WP_Term Object
(
[term_id] => 100
[name] => Affordable pricing
[slug] => pricing
[term_group] => 0
[term_taxonomy_id] => 100
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 30
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[66] => WP_Term Object
(
[term_id] => 66
[name] => Benefit sharing
[slug] => benefit-revenue-sharing
[term_group] => 0
[term_taxonomy_id] => 66
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 10
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[53] => WP_Term Object
(
[term_id] => 53
[name] => Business model
[slug] => business-model
[term_group] => 0
[term_taxonomy_id] => 53
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[84] => WP_Term Object
(
[term_id] => 84
[name] => Confidentiality
[slug] => confidentiality
[term_group] => 0
[term_taxonomy_id] => 84
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 67
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[271] => WP_Term Object
(
[term_id] => 271
[name] => Donation
[slug] => donation
[term_group] => 0
[term_taxonomy_id] => 271
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 5
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[72] => WP_Term Object
(
[term_id] => 72
[name] => Effects of termination
[slug] => effect-of-termination
[term_group] => 0
[term_taxonomy_id] => 72
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 51
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[281] => WP_Term Object
(
[term_id] => 281
[name] => Ensuring continuity
[slug] => ensuring-continuity
[term_group] => 0
[term_taxonomy_id] => 281
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 35
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[46] => WP_Term Object
(
[term_id] => 46
[name] => Equitable Access
[slug] => access-to-medicines
[term_group] => 0
[term_taxonomy_id] => 46
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[278] => WP_Term Object
(
[term_id] => 278
[name] => Governance
[slug] => roles-responsibilities
[term_group] => 0
[term_taxonomy_id] => 278
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 53
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[80] => WP_Term Object
(
[term_id] => 80
[name] => Indemnification & liability
[slug] => indemnity
[term_group] => 0
[term_taxonomy_id] => 80
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 67
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[257] => WP_Term Object
(
[term_id] => 257
[name] => Information sharing
[slug] => information-sharing-information-sharing
[term_group] => 0
[term_taxonomy_id] => 257
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 57
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[109] => WP_Term Object
(
[term_id] => 109
[name] => Insurance
[slug] => insurance
[term_group] => 0
[term_taxonomy_id] => 109
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 37
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[48] => WP_Term Object
(
[term_id] => 48
[name] => Intellectual Property
[slug] => ip-ownership
[term_group] => 0
[term_taxonomy_id] => 48
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[50] => WP_Term Object
(
[term_id] => 50
[name] => Liability
[slug] => liability
[term_group] => 0
[term_taxonomy_id] => 50
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[88] => WP_Term Object
(
[term_id] => 88
[name] => License Grants
[slug] => license-grants
[term_group] => 0
[term_taxonomy_id] => 88
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 68
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[87] => WP_Term Object
(
[term_id] => 87
[name] => Ownership of IP
[slug] => ownership-ip
[term_group] => 0
[term_taxonomy_id] => 87
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 55
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[70] => WP_Term Object
(
[term_id] => 70
[name] => Payment Structures
[slug] => royalties-and-payments
[term_group] => 0
[term_taxonomy_id] => 70
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 52
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[102] => WP_Term Object
(
[term_id] => 102
[name] => Preparedness & response
[slug] => outbreak-preparedness
[term_group] => 0
[term_taxonomy_id] => 102
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 9
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[268] => WP_Term Object
(
[term_id] => 268
[name] => Product supply
[slug] => supply-purchase-of-products
[term_group] => 0
[term_taxonomy_id] => 268
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 31
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[49] => WP_Term Object
(
[term_id] => 49
[name] => Protecting & sharing information
[slug] => information-sharing
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[90] => WP_Term Object
(
[term_id] => 90
[name] => Protection of IP
[slug] => protection-results
[term_group] => 0
[term_taxonomy_id] => 90
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 44
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[290] => WP_Term Object
(
[term_id] => 290
[name] => Publication of Results
[slug] => publication-of-results
[term_group] => 0
[term_taxonomy_id] => 290
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 41
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[56] => WP_Term Object
(
[term_id] => 56
[name] => Regulatory strategy
[slug] => regulatory-strategy
[term_group] => 0
[term_taxonomy_id] => 56
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 38
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[81] => WP_Term Object
(
[term_id] => 81
[name] => Representations & Warranties
[slug] => warranties
[term_group] => 0
[term_taxonomy_id] => 81
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 58
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[86] => WP_Term Object
(
[term_id] => 86
[name] => Technology transfer
[slug] => technology-transfer
[term_group] => 0
[term_taxonomy_id] => 86
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 26
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[52] => WP_Term Object
(
[term_id] => 52
[name] => Term & termination
[slug] => term-and-termination
[term_group] => 0
[term_taxonomy_id] => 52
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[76] => WP_Term Object
(
[term_id] => 76
[name] => Term of agreement
[slug] => term-of-agreement
[term_group] => 0
[term_taxonomy_id] => 76
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 55
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[74] => WP_Term Object
(
[term_id] => 74
[name] => Termination & withdrawal
[slug] => termination-and-withdrawal
[term_group] => 0
[term_taxonomy_id] => 74
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 53
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[282] => WP_Term Object
(
[term_id] => 282
[name] => Territory access commitments
[slug] => territory-access-commitments
[term_group] => 0
[term_taxonomy_id] => 282
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 35
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
)
[issues_by_slug:GHIAA2019\MapguideSearch:private] => Array
(
[equitable-access] => WP_Term Object
(
[term_id] => 101
[name] => Access plans & principles
[slug] => equitable-access
[term_group] => 0
[term_taxonomy_id] => 101
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 31
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[pricing] => WP_Term Object
(
[term_id] => 100
[name] => Affordable pricing
[slug] => pricing
[term_group] => 0
[term_taxonomy_id] => 100
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 30
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[benefit-revenue-sharing] => WP_Term Object
(
[term_id] => 66
[name] => Benefit sharing
[slug] => benefit-revenue-sharing
[term_group] => 0
[term_taxonomy_id] => 66
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 10
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[business-model] => WP_Term Object
(
[term_id] => 53
[name] => Business model
[slug] => business-model
[term_group] => 0
[term_taxonomy_id] => 53
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[confidentiality] => WP_Term Object
(
[term_id] => 84
[name] => Confidentiality
[slug] => confidentiality
[term_group] => 0
[term_taxonomy_id] => 84
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 67
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[donation] => WP_Term Object
(
[term_id] => 271
[name] => Donation
[slug] => donation
[term_group] => 0
[term_taxonomy_id] => 271
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 5
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[effect-of-termination] => WP_Term Object
(
[term_id] => 72
[name] => Effects of termination
[slug] => effect-of-termination
[term_group] => 0
[term_taxonomy_id] => 72
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 51
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[ensuring-continuity] => WP_Term Object
(
[term_id] => 281
[name] => Ensuring continuity
[slug] => ensuring-continuity
[term_group] => 0
[term_taxonomy_id] => 281
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 35
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[access-to-medicines] => WP_Term Object
(
[term_id] => 46
[name] => Equitable Access
[slug] => access-to-medicines
[term_group] => 0
[term_taxonomy_id] => 46
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[roles-responsibilities] => WP_Term Object
(
[term_id] => 278
[name] => Governance
[slug] => roles-responsibilities
[term_group] => 0
[term_taxonomy_id] => 278
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 53
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[indemnity] => WP_Term Object
(
[term_id] => 80
[name] => Indemnification & liability
[slug] => indemnity
[term_group] => 0
[term_taxonomy_id] => 80
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 67
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[information-sharing-information-sharing] => WP_Term Object
(
[term_id] => 257
[name] => Information sharing
[slug] => information-sharing-information-sharing
[term_group] => 0
[term_taxonomy_id] => 257
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 57
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[insurance] => WP_Term Object
(
[term_id] => 109
[name] => Insurance
[slug] => insurance
[term_group] => 0
[term_taxonomy_id] => 109
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 37
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[ip-ownership] => WP_Term Object
(
[term_id] => 48
[name] => Intellectual Property
[slug] => ip-ownership
[term_group] => 0
[term_taxonomy_id] => 48
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[liability] => WP_Term Object
(
[term_id] => 50
[name] => Liability
[slug] => liability
[term_group] => 0
[term_taxonomy_id] => 50
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[license-grants] => WP_Term Object
(
[term_id] => 88
[name] => License Grants
[slug] => license-grants
[term_group] => 0
[term_taxonomy_id] => 88
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 68
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[ownership-ip] => WP_Term Object
(
[term_id] => 87
[name] => Ownership of IP
[slug] => ownership-ip
[term_group] => 0
[term_taxonomy_id] => 87
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 55
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[royalties-and-payments] => WP_Term Object
(
[term_id] => 70
[name] => Payment Structures
[slug] => royalties-and-payments
[term_group] => 0
[term_taxonomy_id] => 70
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 52
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[outbreak-preparedness] => WP_Term Object
(
[term_id] => 102
[name] => Preparedness & response
[slug] => outbreak-preparedness
[term_group] => 0
[term_taxonomy_id] => 102
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 9
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[supply-purchase-of-products] => WP_Term Object
(
[term_id] => 268
[name] => Product supply
[slug] => supply-purchase-of-products
[term_group] => 0
[term_taxonomy_id] => 268
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 31
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[information-sharing] => WP_Term Object
(
[term_id] => 49
[name] => Protecting & sharing information
[slug] => information-sharing
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[protection-results] => WP_Term Object
(
[term_id] => 90
[name] => Protection of IP
[slug] => protection-results
[term_group] => 0
[term_taxonomy_id] => 90
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 44
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[publication-of-results] => WP_Term Object
(
[term_id] => 290
[name] => Publication of Results
[slug] => publication-of-results
[term_group] => 0
[term_taxonomy_id] => 290
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 41
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[regulatory-strategy] => WP_Term Object
(
[term_id] => 56
[name] => Regulatory strategy
[slug] => regulatory-strategy
[term_group] => 0
[term_taxonomy_id] => 56
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 38
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[warranties] => WP_Term Object
(
[term_id] => 81
[name] => Representations & Warranties
[slug] => warranties
[term_group] => 0
[term_taxonomy_id] => 81
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 58
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[technology-transfer] => WP_Term Object
(
[term_id] => 86
[name] => Technology transfer
[slug] => technology-transfer
[term_group] => 0
[term_taxonomy_id] => 86
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 26
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[term-and-termination] => WP_Term Object
(
[term_id] => 52
[name] => Term & termination
[slug] => term-and-termination
[term_group] => 0
[term_taxonomy_id] => 52
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[term-of-agreement] => WP_Term Object
(
[term_id] => 76
[name] => Term of agreement
[slug] => term-of-agreement
[term_group] => 0
[term_taxonomy_id] => 76
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 55
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[termination-and-withdrawal] => WP_Term Object
(
[term_id] => 74
[name] => Termination & withdrawal
[slug] => termination-and-withdrawal
[term_group] => 0
[term_taxonomy_id] => 74
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 53
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[territory-access-commitments] => WP_Term Object
(
[term_id] => 282
[name] => Territory access commitments
[slug] => territory-access-commitments
[term_group] => 0
[term_taxonomy_id] => 282
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 35
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
)
[filter_issues:GHIAA2019\MapguideSearch:private] => Array
(
)
)
